Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus
LLDAS without any clinical activity accounted for almost 80% of LLDAS visits. This study confirms that all subsets of LLDAS are associated with reduced flare and damage accrual. However, LLDAS without any clinical or serological activity has the strongest protective association with severe flares.
Authors
- Sean O’Neill (ORCID: https://orcid.org/0000-0002-6739-832X)
- Chak Sing Lau (ORCID: https://orcid.org/0000-0001-6698-8355)
- Masayoshi Harigai (ORCID: https://orcid.org/0000-0002-6418-2603)
- Kristine Ng (ORCID: https://orcid.org/0009-0006-6225-2715)
- Mandana Nikpour (ORCID: https://orcid.org/0000-0002-6585-5611)
- Yoshiya Tanaka (ORCID: https://orcid.org/0000-0002-0807-7139)
- Shereen Oon (ORCID: https://orcid.org/0000-0002-6822-5711)
- Jun Kikuchi (ORCID: https://orcid.org/0000-0003-3231-8841)
- Sandra Navarra (ORCID: https://orcid.org/0000-0003-0094-8654)
- Sang‐Cheol Bae (ORCID: https://orcid.org/0000-0003-4658-1093)
- Eric Francis Morand (ORCID: https://orcid.org/0000-0002-9507-3338)
- Nicola Tugnet
- Alberta Hoi (ORCID: https://orcid.org/0000-0002-9416-7383)
- Madelynn Chan (ORCID: https://orcid.org/0000-0002-8102-7664)
- Vera Golder (ORCID: https://orcid.org/0000-0001-5691-4344)
- Leonid Zamora (ORCID: https://orcid.org/0000-0002-4209-4442)
- Yeong‐Jian Jan Wu (ORCID: https://orcid.org/0000-0002-5444-4729)
- Yasuhiro Katsumata (ORCID: https://orcid.org/0000-0003-1654-0119)
- Fiona Goldblatt (ORCID: https://orcid.org/0000-0001-7205-4807)
- Zhuoli Zhang (ORCID: https://orcid.org/0000-0001-7219-9141)
- Yanjie Hao (ORCID: https://orcid.org/0000-0001-8715-259X)
- Worawit Louthrenoo (ORCID: https://orcid.org/0000-0003-3105-6122)
- Jiacai Cho (ORCID: https://orcid.org/0000-0002-4477-3430)
- BMDB Basnayake
- Laniyati Hamijoyo (ORCID: https://orcid.org/0000-0002-1310-674X)
- Rangi Kandane‐Rathnayake (ORCID: https://orcid.org/0000-0001-5397-1482)
- Zhanguo Li (ORCID: https://orcid.org/0000-0002-4422-5485)
- Sargunan Sockalingam (ORCID: https://orcid.org/0000-0002-7266-9526)
- Tsutomu Takeuchi (ORCID: https://orcid.org/0000-0003-1111-8218)
- Aisha Lateef (ORCID: https://orcid.org/0000-0002-0838-7495)
- Ning Li (ORCID: https://orcid.org/0000-0001-8013-5041)
- Yi‐Hsing Chen (ORCID: https://orcid.org/0000-0002-8135-9554)
- Dylan Hansen (ORCID: https://orcid.org/0000-0001-5777-7476)
- Shue-Fen Luo
Institutions
- University of Santo Tomas Hospital (PH)
- The University of Sydney (AU)
- Royal Adelaide Hospital (AU)
- National Yang Ming Chiao Tung University (TW)
- The University of Melbourne (AU)
- Chang Gung University (TW)
- Chinese University of Hong Kong (HK)
- University of Occupational and Environmental Health Japan (JP)
- Peking University (CN)
- Keio University (JP)
- Royal Prince Alfred Hospital (AU)
- Liverpool Hospital (AU)
- North Shore Hospital (NZ)
- Tan Tock Seng Hospital (SG)
- Teaching Hospital Kandy (LK)
- Repatriation General Hospital (AU)
- Flinders Medical Centre (AU)
- Chang Gung Memorial Hospital (TW)
- UNSW Sydney (AU)
- University of Malaya (MY)
- Dr. Hasan Sadikin General Hospital (ID)
- St Vincent's Hospital Melbourne (AU)
- Taichung Veterans General Hospital (TW)
- Greenlane Clinical Centre (NZ)
- Keio University Hospital (JP)
- Auckland District Health Board (NZ)
- Linkou Chang Gung Memorial Hospital (TW)
- Monash Health (AU)
- Peking University People's Hospital (CN)
- Peking University First Hospital (CN)
- Tokyo Women's Medical University (JP)
- Hanyang University Seoul Hospital (KR)
- Woodlands Health Campus (SG)
- National University Hospital (SG)
- Hanyang University (KR)
- Chiang Mai University (TH)
- Monash University (AU)
- University of Santo Tomas (PH)
- University of Hong Kong (HK)
- Padjadjaran University (ID)
- Anyang University (KR)
Publication Details
- Journal
- Lupus Science & Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1136/lupus-2024-001217
- Citations
- 2
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- GlaxoSmithKline
- UCB
- National Research Foundation
- University of Melbourne
- National Research Foundation of Korea
- National Health and Medical Research Council
- Janssen Research and Development